INVO Fertility (IVF) Preferred Shares Issued (2024 - 2025)
INVO Fertility (IVF) reported Preferred Shares Issued of $1.7 million for Q3 2025, up 1136.36% year-over-year from $137500.0 in Q3 2024, and up 3972.08% on a QoQ basis from -$43904.0 in Q4 2024.
INVO Fertility (IVF) has 2 years of Preferred Shares Issued data on file, last reported at $1.7 million in Q3 2025.
- Quarterly Preferred Shares Issued rose 1136.36% year-over-year to $1.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.8 million (changed N/A YoY) and the FY2024 annual result came in at $1.6 million, changed N/A from the prior year.
- Preferred Shares Issued improved to $1.7 million in Q3 2025 per IVF's latest filing, from -$43904.0 in the prior quarter.
- Across five years, Preferred Shares Issued topped out at $1.7 million in Q3 2025 and bottomed at -$43904.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.70 Mn |
| Dec 31, 2024 | -43,904.00 |
| Dec 31, 2024 | -43,904.00 |
| Sep 30, 2024 | 137,500.00 |
| Sep 30, 2024 | 137,500.00 |
| Jun 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |